Iocarmic acid
{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 407427669 | IUPAC_name = 3-(5-{[3-carboxy-2,4,6-triiodo-5-(methylcarbamoyl)phenyl]carbamoyl}pentanamido)-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid | image = Iocarmic wiki str.png
| tradename =
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category =
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US =
| legal_status =
| routes_of_administration =
| bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion =
| CAS_number_Ref = | CAS_number = 10397-75-8 | ATC_prefix = V08 | ATC_suffix = AA08 | PubChem = 25229 | DrugBank_Ref = | DrugBank = | UNII_Ref = | UNII = 82PB24K6TZ | KEGG_Ref = | KEGG = D01099 | ChemSpiderID_Ref = | ChemSpiderID = 23564
| C=24 | H=20 | I=6 | N=4 | O=8 | molecular_weight = 1253.86 g/mol | synonyms = 3-[[6-[[3-Carboxy-2,4,6-triiodo-5-(methylcarbamoyl)phenyl]amino]-6-oxohexanoyl]amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid | smiles = CNC(=O)c1c(c(c(c(c1I)NC(=O)CCCCC(=O)Nc2c(c(c(c(c2I)C(=O)O)I)C(=O)NC)I)I)C(=O)O)I | InChI = 1/C24H20I6N4O8/c1-31-21(37)9-13(25)11(23(39)40)17(29)19(15(9)27)33-7(35)5-3-4-6-8(36)34-20-16(28)10(22(38)32-2)14(26)12(18(20)30)24(41)42/h3-6H2,1-2H3,(H,31,37)(H,32,38)(H,33,35)(H,34,36)(H,39,40)(H,41,42) | InChIKey = SMQYOVYWPWASGU-UHFFFAOYAT | StdInChI_Ref = | StdInChI = 1S/C24H20I6N4O8/c1-31-21(37)9-13(25)11(23(39)40)17(29)19(15(9)27)33-7(35)5-3-4-6-8(36)34-20-16(28)10(22(38)32-2)14(26)12(18(20)30)24(41)42/h3-6H2,1-2H3,(H,31,37)(H,32,38)(H,33,35)(H,34,36)(H,39,40)(H,41,42) | StdInChIKey_Ref = | StdInChIKey = SMQYOVYWPWASGU-UHFFFAOYSA-N
}}
WikiDoc Resources for Iocarmic acid |
Articles |
---|
Most recent articles on Iocarmic acid Most cited articles on Iocarmic acid |
Media |
Powerpoint slides on Iocarmic acid |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Iocarmic acid at Clinical Trials.gov Trial results on Iocarmic acid Clinical Trials on Iocarmic acid at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Iocarmic acid NICE Guidance on Iocarmic acid
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Iocarmic acid Discussion groups on Iocarmic acid Patient Handouts on Iocarmic acid Directions to Hospitals Treating Iocarmic acid Risk calculators and risk factors for Iocarmic acid
|
Healthcare Provider Resources |
Causes & Risk Factors for Iocarmic acid |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Iocarmic acid is a molecule used as a contrast medium.